Sara Giovani

Sara Giovani


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2025 in Cardiogenetics
Verified
Journal Article
Open access
PDF file
SGSara Giovani
Sara Giovani
ABAdelaide Ballerini
Adelaide Ballerini
AGAlessia Gozzini
Alessia Gozzini
MLMichele Di Lorenzo
Michele Di Lorenzo
DMDavide Mei
Davide Mei
FGFrancesca Girolami
Francesca Girolami
This study investigates the genetic background of pediatric-onset cardiac channelopathies, a rare group of genetic disorders causing arrhythmias and sometimes sudden death, whose genetic background remains partially unknown. The research analyzed 59 pediatric patients (<18 years of age) diagnosed with different channelopathies (LQTS, BrS, CPVT, SQTS, and conduction disorders), along with 40 of their family members, using Next-Generation Sequencing (NGS) after genetic counseling. A causative genetic variant was found in 47% of cases, mainly in the KCNQ1 (42%), RYR2 (16%), CACNA1C (10%), and SCN5A (10%) genes. Notably, a de novo large deletion in KCNH2 was detected in an LQTS patient, and a pathogenic CALM1 variant was identified in a child. A compound heterozygous KCNQ1 was consistent with Jervell and Lange-Nielsen syndrome. In light of these data, genetic testing is crucial for diagnosis, prognosis, and treatment planning; cascade screening allowed early risk identification and preventive interventions for family members. Expanding NGS technologies and research on new candidate genes may enhance personalized therapies in the future.

22 July 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
SGSara Giovani
Sara Giovani
ABAdelaide Ballerini
Adelaide Ballerini
AGAlessia Gozzini
Alessia Gozzini
MLMichele Di Lorenzo
Michele Di Lorenzo
DMDavide Mei
Davide Mei
FGFrancesca Girolami
Francesca Girolami
This study investigates the genetic background of pediatric-onset cardiac channelopa-thies, a rare group of genetic disorders causing arrhythmias and sometimes sudden death whose genetic background remains partially unknown. The research analyzed 59 pediatric patients (< 18 years of age) diagnosed with different channelopathies (LQTS, BrS, CPVT, SQTS, and conduction disorders), along with 40 of their family members, using Next Generation Sequencing (NGS) after genetic counselling. A causative genetic variant was found in 47% of cases, mainly in KCNQ1 (42%), RYR2 (16%), CACNA1C (10%), and SCN5A (10%) genes. Notably, a de novo large deletion in KCNH2 has been detected in an LQTS patient, and a pathogenic CALM1 variant has been identified in a child. A compound heterozygous KCNQ1 was consistent with the Jervell and Lange-Nielsen syndrome. In the light of these data genetic testing is crucial for diagnosis, prognosis and treatment planning; cascade screening allowed early risk identification and preventive interventions for family members. Expanding NGS technologies and research on new candidate genes may enhance personalized therapies in the future.